SynthesisFrontiers in pharmacology2019

Safety and Efficacy of Anti-PD-1 Monoclonal Antibodies in Patients With Relapsed or Refractory Lymphoma: A Meta-Analysis of Prospective Clinic Trails.

Hui Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.